Zealand Pharma Plummets as Gastrointestinal Side Effects Cloud Survodutide’s Commercial Path
Shares of Zealand Pharma crashed following data showing a 19% dropout rate due to GI issues in its experimental weight loss drug survodutide.
Shares of Zealand Pharma crashed following data showing a 19% dropout rate due to GI issues in its experimental weight loss drug survodutide.
Five leading researchers, including the editor-in-chief of Diabetes Care, were escorted out of the American Diabetes Association meeting in New Orleans over political protests.
Dozens of Palestinians evacuated to Iraq for urgent medical care find themselves trapped in Baghdad due to confiscated travel documents and diplomatic failures.
The U.S. government is accelerating mRNA vaccine development for the Bundibugyo virus as Ebola outbreaks persist, granting Moderna $50 million for rapid prototyping.
Triomics has raised $22 million to scale its specialized AI platform designed to automate clinical trial matching and medical record synthesis for cancer centers.